Viral reactivation imitates relapse of pemphigus vulgaris in an immunosuppressed patient

J Dtsch Dermatol Ges. 2017 Nov;15(11):1144-1146. doi: 10.1111/ddg.13343. Epub 2017 Sep 18.

Authors

Anna Pushkarevskaya¹, Mona Bidier¹, Martin Hartmann¹, Alexander Enk¹, Eva Hadaschik¹

Affiliation

¹ Department of Dermatology, University Hospital Heidelberg, Ruprecht Karls University, Heidelberg, Germany.

PMID: 28921892
DOI: 10.1111/ddg.13343

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Autoantibodies / blood
Combined Modality Therapy
Cytomegalovirus / drug effects
Debridement
Desmoglein 1 / immunology
Desmoglein 3 / immunology
Diagnosis, Differential
Drug Therapy, Combination
Female
Follow-Up Studies
Foscarnet / adverse effects
Foscarnet / therapeutic use
Herpesvirus 1, Human / drug effects
Herpesvirus 2, Human / drug effects
Herpesvirus 3, Human / drug effects
Humans
Immunosuppression Therapy* / adverse effects
Middle Aged
Mycophenolic Acid / adverse effects
Mycophenolic Acid / therapeutic use
Pemphigus / diagnosis
Pemphigus / immunology*
Pemphigus / pathology
Prednisolone / adverse effects
Prednisolone / therapeutic use
Recurrence
Virus Activation / drug effects
Virus Activation / immunology*

Substances

Autoantibodies
DSG1 protein, human
DSG3 protein, human
Desmoglein 1
Desmoglein 3
Foscarnet
Prednisolone
Mycophenolic Acid